Cargando…

Lipids and Lipoproteins in Atherosclerosis

Detalles Bibliográficos
Autores principales:	Chroni, Angeliki, Leondaritis, George, Karlsson, Helen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2011
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3317094/ https://www.ncbi.nlm.nih.gov/pubmed/22523690 http://dx.doi.org/10.1155/2011/160104

Ejemplares similares

Lipids and Lipoproteins in Atherosclerosis
por: Bezsonov, Evgeny, et al.
Publicado: (2023)

Lipids and Lipoproteins in Health and Disease
por: Bezsonov, Evgeny E., et al.
Publicado: (2021)

Lipids and Lipoproteins in Health and Disease: Focus on Targeting Atherosclerosis
por: Lee, Chih-Kuo, et al.
Publicado: (2021)

Effect of Lipids and Lipoproteins on Hematopoietic Cell Metabolism and Commitment in Atherosclerosis
por: Baragetti, Andrea, et al.
Publicado: (2021)

Lipids, lipoprotein distribution and depressive symptoms: the Multi-Ethnic Study of Atherosclerosis
por: Ong, K L, et al.
Publicado: (2016)

Which is the Best Predictor for the Development of Atherosclerosis Among Circulating Lipoprotein Lipase, Hepatic Lipase, and Endothelial Lipase?
por: Kobayashi, Junji
Publicado: (2019)

Immune Response to Lipoproteins in Atherosclerosis
por: Samson, Sonia, et al.
Publicado: (2012)

Endothelial Transcytosis of Lipoproteins in Atherosclerosis
por: Zhang, Xinbo, et al.
Publicado: (2018)

Carotid Atherosclerosis, Ultrasound and Lipoproteins
por: Iannuzzi, Arcangelo, et al.
Publicado: (2021)

Lipoprotein (a), Inflammation, and Atherosclerosis
por: Di Fusco, Stefania Angela, et al.
Publicado: (2023)

Atherosclerosis Calcification: Focus on Lipoproteins
por: Neels, Jaap G., et al.
Publicado: (2023)

Special Issue: New Insight into the Molecular Role of Lipids and Lipoproteins in Vascular Diseases
por: Benitez, Sonia, et al.
Publicado: (2023)

Lipoprotein (a): A Frustrating Final Frontier in Lipid Management?
por: Libby, Peter
Publicado: (2016)

The Importance of Lipoprotein Lipase Regulation in Atherosclerosis
por: Kumari, Anni, et al.
Publicado: (2021)

Triglyceride and Triglyceride-Rich Lipoproteins in Atherosclerosis
por: Zhang, Bai-Hui, et al.
Publicado: (2022)

Low-density lipoprotein particles in atherosclerosis
por: Qiao, Ya-Nan, et al.
Publicado: (2022)

MicroRNA-30c reduces hyperlipidemia and atherosclerosis by decreasing lipid synthesis and lipoprotein secretion
por: Soh, James, et al.
Publicado: (2013)

An Intriguing and Important Concept Relevant to Oxidized Low-Density Lipoprotein and Atherogenesis is Still Problematic for its Contribution to the Better Understanding of Clinical Atherosclerosis
por: Yoshida, Hiroshi
Publicado: (2018)

The Apolipoprotein M–Sphingosine-1-Phosphate Axis: Biological Relevance in Lipoprotein Metabolism, Lipid Disorders and Atherosclerosis
por: Arkensteijn, Bas W. C., et al.
Publicado: (2013)

High density lipoproteins and atherosclerosis: emerging aspects
por: Sala, Federica, et al.
Publicado: (2012)

High density lipoprotein mimicking nanoparticles for atherosclerosis
por: Chen, Jun, et al.
Publicado: (2020)

Lipoprotein(a)—The Crossroads of Atherosclerosis, Atherothrombosis and Inflammation
por: Ugovšek, Sabina, et al.
Publicado: (2021)

Lipoprotein sialylation in atherosclerosis: Lessons from mice
por: Yu, Liming, et al.
Publicado: (2022)

Low-Density Lipoprotein Cholesterol, Structural Atherosclerosis, and Functional Atherosclerosis in Older Japanese
por: Shimizu, Yuji, et al.
Publicado: (2022)

Retraction: MicroRNA-135a alleviates lipid accumulation and inflammation of atherosclerosis through targeting lipoprotein lipase
por: Fisher, Laura
Publicado: (2021)

Attenuating lipid metabolism in atherosclerosis: The potential role of Anti-oxidative effects on low-density lipoprotein of herbal medicines
por: Duan, Huxinyue, et al.
Publicado: (2023)

Biocompatible PEO-b-PCL Nanosized Micelles as Drug Carriers: Structure and Drug–Polymer Interactions
por: Chroni, Angeliki, et al.
Publicado: (2020)

Nano-Assemblies from Amphiphilic PnBA-b-POEGA Copolymers as Drug Nanocarriers
por: Chroni, Angeliki, et al.
Publicado: (2021)

Curcumin-Loaded PnBA-b-POEGA Nanoformulations: A Study of Drug-Polymer Interactions and Release Behavior
por: Chroni, Angeliki, et al.
Publicado: (2023)

Oxidized low density lipoprotein, stem cells, and atherosclerosis
por: Yang, Hui, et al.
Publicado: (2012)

High-Density Lipoprotein, Lecithin: Cholesterol Acyltransferase, and Atherosclerosis
por: Ossoli, Alice, et al.
Publicado: (2016)

Lipoprotein(a) and its role in inflammation, atherosclerosis and malignancies
por: Orsó, Evelyn, et al.
Publicado: (2017)

Lipoprotein(a) Modulates Carotid Atherosclerosis in Metabolic Syndrome
por: Cremonini, Anna Laura, et al.
Publicado: (2022)

Lipoprotein(a): Role in atherosclerosis and new treatment options
por: Naglic, Dragana Tomic, et al.
Publicado: (2023)

Lipoprotein(a): An Enigmatic Sheep in the Lipoprotein Herd
por: Shapiro, Michael D., et al.
Publicado: (2020)

Retracted Article: MicroRNA-135a alleviates lipid accumulation and inflammation of atherosclerosis through targeting lipoprotein lipase
por: Li, Juan, et al.
Publicado: (2019)

Effect of apoA-I Mutations in the Capacity of Reconstituted HDL to Promote ABCG1-Mediated Cholesterol Efflux
por: Daniil, Georgios, et al.
Publicado: (2013)

Sortilin and atherosclerosis
por: Mortensen, Martin B., et al.
Publicado: (2015)

Atherosclerosis and Autoimmunity
por: Spinelli, Francesca Romana, et al.
Publicado: (2018)

Inflammation and Atherosclerosis
por: Ley, Klaus
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_s9j31ala6buh6u15p1h77cgnb6